Improving patient safety and reducing specimen errors remain top priorities among laboratories, with 90% of surveyed labs stating that specimen labeling errors are a key concern for their labs.
Studies indicate an error rate of 0.1% on mislabeled sample tests in the US. It may seem like a minuscule number but weighing against approximately 8 billion sample tests performed in the US annually is not a small number to ignore.
A specimen or patient identification error has cascading effects to wrong treatment that can also be life-threatening.
Manual tracking of specimens dispatched from the operating rooms to the pathology labs often causes errors like mislabeling and delays in diagnosis.
A medical device company realized the potential to eliminate such errors by digitizing the process and leveraging the right technology with Virtusa as their IT consultant and implementation partner.